Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
14 Results for "
MGD
" in MedChemExpress (MCE) Product Catalog:
Products (14)
14 Results for "MGD" in MCE Product Catalog:
1
Cat. No.: HY-P99623
CAS No.: 1664355-28-5
Synonyms: MGD006; S80880
Cat. No.: HY-P99573
CAS No.: 2245725-04-4
Synonyms: MGD-013
Target:
Research Areas:
Cat. No.: HY-P99714
CAS No.: 2416595-46-3
Synonyms: MGD019
Target:
Research Areas:
Cat. No.: HY-W143531
CAS No.: 133331-77-8
Synonyms: NOV03; SHR8058
Target:
Research Areas:
Perfluorohexyloctane (NOV03), a semifluorinated alkane, reduces tear film instability in Meibomian gland dysfunction and evaporative dry eye disease. Perfluorohexyloctane is a long-term tamponade agent. Perfluorohexyloctane increases tear film breakup time and lipid layer thickness .
Cat. No.: HY-168615
CAS No.: 2991818-13-2
Target:
Research Areas:
MGD-28 is a potent, orally active, Cereblon (CRBN)-dependent IKAROS protein degrader that degrades IKZF1 (DC50=3.8 nM), IKZF2 (DC50=56.3 nM), and IKZF3 (DC50=7.1 nM) in a dose-dependent manner. In addition, MGD-4 also degrades CK1α (DC50=7.8 nM). MGD-28 has antiproliferative activity and can be used in multiple myeloma research .
Cat. No.: HY-P991086
Synonyms: PRV-3279
Target:
Research Areas:
Cat. No.: HY-175502
CAS No.: 2991818-12-1
Target:
Research Areas:
MGD-22, a molecular glue, is an orally active IKZF1/2/3 degrader with DC50 values of 8.33 nM, 9.91 nM, and 5.74 nM, respectively. MGD-22 exhibits extremely potent anti-proliferative activity against diverse hematological cancer cells. MGD-22 induces apoptosis in cancer cells. MGD-22 demonstrates potent anti-tumor efficacy in mice bearing NCI-H929 xenografts or WSU-DLCL-2 xenografts. MGD-22 can be used for the study of hematological cancers, including multiple myeloma (MM), acute myeloid leukemia (AML), and diffuse large B-cell lymphoma (DLBCL) .
Cat. No.: HY-168614
CAS No.: 2991817-99-1
Target:
Research Areas:
MGD-4 is an orally active, Cereblon (CRBN)-dependent IKAROS protein degrader that degrades IKZF1 (DC50=67.2 nM), IKZF2 (DC50=918.2 nM), and IKZF3 (DC50=95.8 nM) in a dose-dependent manner. MGD-4 effectively inhibits the growth of multiple myeloma .
Cat. No.: HY-P991188
Target:
Research Areas:
Cat. No.: HY-N16337
CAS No.: 51424-47-6
Hydrogenated MGDG is a type of glycolipid. Monogalactosyldiacylglycerol (MGDG), a galactosylglycerolipid, is a major lipid in the thylakoid membrane of the chloroplast of leaves. It is also localized in the roots, fruits and grains. MGDG is synthesized from Monogalactosyldiacylglycerol synthase 1 (MGD1). It is a precursor for digalactosyldiacylglycerol (DGDG).
Cat. No.: HY-180538A
Target:
Research Areas:
MRT-31619 formate is a molecular gel degrader (MGD) targeting CRBN. MRT-31619 formate drives the self-dimerization of the E3 ligase by mimicking the degradation subunit, and promotes its rapid, effective and selective degradation through the ubiquitin-proteasome system .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
